Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180

Bullous pemphigoid (BP) is a common autoimmune blistering disease in which autoantibodies target the hemidesmosomal components BP180 and/or BP230 in basal keratinocytes. In BP, 80 to 90% of autoantibodies target the juxtamembranous extracellular non-collagenous 16th A (NC16A) domain of BP180. Recent...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yosuke Mai, Wataru Nishie, Kentaro Izumi, Hiroshi Shimizu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2019-05-01
Edice:	Frontiers in Immunology
Témata:	bullous pemphigoid dipeptidyl peptidase-IV inhibitor dipeptidyl peptidase-IV inhibitor-associated bullous pemphigoid autoantibodies IgG subclass BP180
On-line přístup:	https://www.frontiersin.org/article/10.3389/fimmu.2019.01224/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!